[2602.17888] Machine Learning Based Prediction of Surgical Outcomes in Chronic Rhinosinusitis from Clinical Data
Summary
This article explores the application of machine learning to predict surgical outcomes in patients with chronic rhinosinusitis, demonstrating a model that surpasses expert predictions in accuracy.
Why It Matters
The integration of machine learning in clinical settings can enhance decision-making processes, potentially leading to better patient outcomes and reduced healthcare costs. This study highlights the importance of utilizing standardized clinical data to inform surgical interventions, addressing a significant gap in current medical practices.
Key Takeaways
- Machine learning models can accurately predict surgical outcomes in chronic rhinosinusitis.
- The study achieved 85% classification accuracy, outperforming expert clinicians.
- Utilizing preoperative data can help identify patients who may not benefit from surgery.
- The findings support personalized care in surgical decision-making.
- This research underscores the potential of AI to improve healthcare efficiency.
Computer Science > Machine Learning arXiv:2602.17888 (cs) [Submitted on 19 Feb 2026] Title:Machine Learning Based Prediction of Surgical Outcomes in Chronic Rhinosinusitis from Clinical Data Authors:Sayeed Shafayet Chowdhury, Karen D'Souza, V. Siva Kakumani, Snehasis Mukhopadhyay, Shiaofen Fang, Rodney J. Schlosser, Daniel M. Beswick, Jeremiah A. Alt, Jess C. Mace, Zachary M. Soler, Timothy L. Smith, Vijay R. Ramakrishnan View a PDF of the paper titled Machine Learning Based Prediction of Surgical Outcomes in Chronic Rhinosinusitis from Clinical Data, by Sayeed Shafayet Chowdhury and 11 other authors View PDF HTML (experimental) Abstract:Artificial intelligence (AI) has increasingly transformed medical prognostics by enabling rapid and accurate analysis across imaging and pathology. However, the investigation of machine learning predictions applied to prospectively collected, standardized data from observational clinical intervention trials remains underexplored, despite its potential to reduce costs and improve patient outcomes. Chronic rhinosinusitis (CRS), a persistent inflammatory disease of the paranasal sinuses lasting more than three months, imposes a substantial burden on quality of life (QoL) and societal cost. Although many patients respond to medical therapy, others with refractory symptoms often pursue surgical intervention. Surgical decision-making in CRS is complex, as it must weigh known procedural risks against uncertain individualized outcomes. In this stu...